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Abstract
During viral infections, single- and double-stranded RNA (ssRNA and dsRNA) are recognized by the host and induce innate
immune responses. The cellular enzyme ADAR-1 (adenosine deaminase acting on RNA-1) activation in virally infected cells
leads to presence of inosine-containing RNA (Ino-RNA). Here we report that ss-Ino-RNA is a novel viral recognition element.
We synthesized unmodified ssRNA and ssRNA that had 6% to16% inosine residues. The results showed that in primary
human cells, or in mice, 10% ss-Ino-RNA rapidly and potently induced a significant increase in inflammatory cytokines, such
as interferon (IFN)-b (35 fold), tumor necrosis factor (TNF)-a (9.7 fold), and interleukin (IL)-6 (11.3 fold) (p,0.01). Flow
cytometry data revealed a corresponding 4-fold increase in influx of neutrophils into the lungs by ss-Ino-RNA treatment. In
our in vitro experiments, treatment of epithelial cells with ss-Ino-RNA reduced replication of respiratory syncytial virus (RSV).
Interestingly, RNA structural analysis showed that ss-Ino-RNA had increased formation of secondary structures. Our data
further revealed that extracellular ss-Ino-RNA was taken up by scavenger receptor class-A (SR-A) which activated
downstream MAP Kinase pathways through Toll-like receptor 3 (TLR3) and dsRNA-activated protein kinase (PKR). Our data
suggests that ss-Ino-RNA is an as yet undescribed virus-associated innate immune stimulus.
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Introduction
Inflammatory responses that are generated during viral
infections are critical for antiviral immune responses. The exact
viral recognition elements that activate cells to induce pro-
inflammatory signals are not completely characterized. Viral
recognition elements such as dsRNA and 59-triphosphate single-
stranded RNA are recognized by several cellular pathways
including scavenger receptor class-A (SR-A), dsRNA-activated
protein kinase (PKR), retinoic acid inducible gene-1 (RIG-I), Toll-
like receptor 3 (TLR3), melanoma differentiation-associated
antigen 5 (MDA5), NLR family, pyrin domain-containing 3
(NLRP3) and mitochondrial antiviral signaling proteins (MAVS)
[1–7]. The intracellular or extracellular interaction of cells with
viral recognition elements results in activation of innate immune
responses as indicated by expression of inflammatory cytokines
and chemokines [1–4,7–11].
In addition to the innate immune inflammation, viral
recognition elements trigger establishment of an antiviral state,
under which each cell resists viral infection. The resistance to viral
infection is in part through inhibition of viral replication by
perturbation of RNA and protein synthesis. Determining the exact
mechanisms by which immune and antiviral responses are
activated is essential for understanding viral pathogenesis.
Based on previous data published by our laboratory and others,
we hypothesized that any ssRNA, of cellular or viral origin,
modified by the presence of inosines (Ino-RNA) was an innate
recognition element. RNA with high inosine content is not
commonly found in normally growing eukaryotic cells but it is
present during infections with DNA and RNA viruses such as
polyomavirus, Rous-associated virus, vesicular stomatitis virus,
measles virus, and respiratory syncytial virus [12–19]. During virus
infections, the occurrence of inosines in RNA is by activation of
the enzyme ADAR-1 (adenosine deaminase that acts on RNA-1).
Once activated, ADAR-1 deaminates adenines into inosines, also
termed A-I editing [20–25], which occurs in both viral and cellular
RNAs. Although the percentage on A-I editing during infection
varies, there is evidence for high inosine content within the
infected cells [14,20,22,25–28]. In fact, based on percentage of
adenosine conversion, there are two types of A-I editing. Highly
selective deamination shows less than 10% adenosine deamina-
tion, While less selective deamination, also called hypermutation,
produce A-I editing with more than 10% and often as high as 50%
of all adenines can be converted to inosines, which leads to
approximately 12.5% inosine content in the RNA [14,23,29].
Extracellular Ino-RNA is generated during viral infections. Cell
lysis occurs frequently during viral infections, which results in the
release of cell content, including intracellular generated Ino-RNA,
into the extracellular space. Extracellular dsRNA has been shown
to be able to stimulate antiviral responses in neighboring,
uninfected cells [30]. However, the role of extracellular Ino-
RNA is currently not clear.
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presence of inosines in ssRNA is a potent inducer of inflammatory
cytokines and the antiviral state during virus infection. Our studies
showed that in PHBE cells, primary human alveolar macrophages,
or C57BL/6 mice, treatment with Ino-RNA significantly induced
interferon (IFN-b), tumor necrosis factor (TNF-a), and interleukin
(IL-6). Furthermore, treatment of epithelial cells with Ino-RNA led
to a reduction in RSV replication. Structural analysis revealed that
the presence of inosines increased formation of secondary
structures. Extracellular Ino-RNA was internalized by SR-A-
mediated endocytosis, which activated downstream MAP kinase
pathways through the well-characterized dsRNA specific proteins,
TLR3 and PKR. Based on our studies, we suggest that Ino-RNA,
of viral or cellular origin, in the surrounding tissue after release
from infected cells is a signal for the presence of virus infections.
Materials and Methods
Cell culture and virus infection
Primary human bronchial epithelial cell (PHBE) were grown in
bronchial epithelial basal medium (BEBM) supplemented with
growth factors (Lonza Walkersville, Walkersville, MD, USA) at
37uC in a 5% CO2 humidified chamber. BEAS-2B bronchial
epithelial cell line was maintained in Dulbecco’s Modification of
Eagle’s Medium/Ham’s F-12 with 5% fetal calf serum. Cells, at
90% confluence, were treated with different RNA preparations
and total cellular RNA or proteins were then extracted at
indicated times.
Isolation of primary human alveolar macrophages was ap-
proved by a written consent by the University of North Carolina
School of Medicine Committee on the protection of the rights of
human subjects. Healthy, non-smoking male volunteers, 18 to 40
year of age, underwent fiberoptic bronchoscopy with lavage to
procure human alveolar macrophages. Samples were put on ice
immediately after aspiration and centrifuged at 300 x g for 10 min
at 4uC. Cells were washed twice with RPMI-1640, and re-
suspended in RPMI-1640 at 1610
6 cells/ml.
For virus infection, BEAS-2B or PHBE cells were seeded and
allowed to reach 70% confluency. Cells were then treated for 10%
Ino-RNA, N-RNA, or IFN-a. After 24 hr, cells were infected with
respiratory syncytial virus (RSV-A2) at multiplicity of infection
(MOI) of 0.1 plaque forming unit (PFU)/cell. Following infection
for 24 hr, cells were harvested for total RNA extraction.
Viral titers were measured by standard plaque assay using HEp-
2 cells. Plaques were visualized by using goat anti-RSV antibody
(Fitzgerald Industries International, Acton, MA, USA) and HRP-
conjugated anti-goat secondary antibody (Sigma Chemicals, St.
Louis, MO, USA).
In vitro RNA synthesis
pGEM-Luc (p-Luc) vector (Promega, Madison, WI, USA), was
linearized with HindIII and purified by Wizard DNA Cleanup kit
(Promega, Madison, WI, USA). Run-off transcription of normal p-
Luc RNA (transcript a) was performed using the Megascript T7 kit
(Ambion, Austin, TX, USA) according to the manufacturer’s
protocol with nucleotide triphosphates at 7.5 mM each. p-Luc
RNA containing 6% Inosine (transcript b) was transcribed by
ATP, GTP, CTP and UTP concentrations to 5.6 mM each, and
including 9.4 mM ITP in the reaction. RNA containing 10–11%
Inosine (transcript c) was transcribed by adjusting ATP, GTP,
CTP and UTP concentrations to 2.8 mM each, and including
9.4 mM ITP in the reaction. RNA containing 16% Inosine
(transcript d) was transcribed by further reducing GTP concen-
tration to 1.0 mM, where ATP, UTP, and CTP were kept at
2.8 mM each, ITP concentration was kept at 9.4 mM. All
transcription reactions were performed at 37uC for 2 hr, followed
by digestion of the template DNA and purification using
Megascript purification kit according to manufacturer’s protocol
(Ambion, Austin, TX, USA). The transcripts were then quanti-
tated by UV absorbance, and were analyzed by 1% agarose gel
electrophoresis.
Inosine content analysis
Transcripts were characterized for inosine content by digestion
of 3.5 mg of transcript with 2 units each of snake venom
phosphodiesterase and calf Intestinal alkaline phosphatase in
buffer containing 10 mM Tris pH 8.8, and 2 mM MgCl2 (40 ml
total reaction volume) for 2 hr at 37uC. Digested products were
analyzed by high performance liquid chromotography (HPLC)
using C-18 reverse phase column. Relative nucleoside composition
was determined by peak integration using Breeze software (Waters
Corporation, Milford, MA, USA), and is represented as a ratio of
area under each nucleoside peak.
RNA extraction and RT-PCR
TRIzol total RNA isolation reagent (Invitrogen, Carlsbad, CA,
USA) was used for RNA extraction. First strand cDNA was
synthesized using superscript reverse transcriptase (Invitrogen,
Carlsbad, CA, USA). cDNA synthesis was performed using 0.5 mg
total RNA in reverse transcription reaction. Following reverse
transcription, 2 ml of cDNA was amplified by RT-PCR. Each
experiment was performed in duplicate in 96 well plates using 1 X
Sybr Green master mix (Bio-Rad, Hercules, CA, USA) in a final
volume of 25 ml. The statistical analysis was performed using
parametric two-tailed unpaired t-test with Welch’s correction. The
sequences of primers were as follows:
IFN-b forward, CAGCAGTTCCAGAAGGAGGA
IFN-b reverse, AGCCAGTGCTCGATGAATCT
TNF-a forward, GGAGAAGGGTGACCGACTCA
TNF-a reverse, TGCCCAGACTCGGCAAAG
IL-6 forward, ATT CTG CGC ACG TTT AAG GA
IL-6 reverse, ATC TGA GGT GCC CAT GCT AC
IL-8 forward, tctggcaaccctagtctgct
IL-8 reverse, gcttccacatgtcctcacaa
RANTES forward, TACCATGAAGGTCTCCGC
RANTES reverse, GACAAAGACGACTGCTGG
RSV-NS1 forward, CACAAACACAATGCCATTCA
RSV-NS1 reverse, AGAGATGGGCAGCAATTCAT
GAPDH forward, GGACCTGACCTGCCGTCTAG
GAPDH reverse, TAGCCCAGGATGCCCTTGAG
Cell extraction, protein kinase assay, protein purification
and western blot analysis
For total cellular protein isolation, PHBE cells were washed 2X
in phosphate-buffered saline (PBS) and equal numbers of cells
were lysed using 1X SDS-sample buffer with 2.5% b-mercapto-
ethanol. Prior to electrophoresis, proteins were denatured by
heating the samples at 95uC for 5 min. To shear the chromosomal
DNA, samples were passed through a 26G needle several times.
The proteins were then resolved on a 10% SDS-PAGE and were
electrotransferred onto nitrocellulose membranes. The immuno-
blotted proteins were visualized using the enhanced chemilumi-
nescence (ECL) western blot detection system (Amersham,
Arlington Heights, IL, USA). For in vitro kinase assays, cell
extracts from BEAS-2B cells were prepared using a buffer
containing nonidet-p40 detergent and were used for in vitro PKR
activation as previously described with minor modification [31].
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E3L, reovirus s3 protein and Galpha-i protein (as a negative
control, a generous gift from Dr. Lutz Birnbaumer, NIEHS) were
grown in E.Coli and purified by affinity chromatography.
Signaling antibodis were used according to the manufacturer’s
instructions. Rabbit antibodies were used to detect p38 MAPK,
phospho-p38 MAPK, JNK, phospho-JNK, phospho-eIF-2a,
MDA5 and RIG-I (Cell Signaling Technology, Beverly, MA,
USA), TLR3 (Sigma Chemicals, St. Louis, MO, USA), PKR and
phospho-PKR (Epitomics Inc., Burlingame, CA, USA).
siRNA knockdown
The sequences targeted by chemically synthesized small
interfering RNAs (Thermo Scientific, Asheville, NC, USA) in
transient knockdown experiments were as follows:
TLR3 gene, GGTATAGCCAGCTAACTAG
PKR gene, GCAGGGAGTAGTACTTAAATA
RIG-I gene, GGAAGAGGTGCAGTATATT
MDA5 gene, GGTGAAGGAGCAGATTCAG
PHBE cells were transfected with TLR3-siRNA, RIG-I-siRNA,
MDA5-siRNA, or control-siRNA (30 nM) using DharmaFECT
transfection reagent (Thermo Scientific, Asheville, NC, USA)
according to the manufacturer’s instructions. 72 hr after the
transfection, cells were stimulated with N-RNA or 10% Ino-RNA.
Then, cytokine production was investigated at mRNA level and
the phosphorylation state of MAPKs was determined by western
blot analysis after.
RNA structure analysis
Non-denaturing gel electrophoresis of RNA was performed
using 0.6% agarose gel in the presence or absence of 120 mM
KCl, 4 mM MgCl2. Loading buffer consisted of the running buffer
with 40% sucrose. For Denaturing gel electrophoresis, we used 1%
agarose gel with 2% formaldehyde and 10 mM MOPS. Prior to
loading, samples were heated for 10 min at 65uC. For RNA
structural analysis using fluorescence spectrum we used acridine
orange RNA-binding dye. RNA at 5 mg/ml was dissolved in buffer
containing 12 mM Hepes (PH 7.5), 120 mM KCl, 4 mM MgCl2.
Spectral analysis was performed on a SpectraMax Gemini XS
(Molecular Devices, Sunnyvale, CA, USA) with excitation at
460 nm and emission maximum at 530 nm.
Animal experiments and flow cytometry
All experiments were performed in accordance with the Animal
Welfare Act and the U.S. Public Health Service Policy on
Humane Care and Use of Laboratory Animals after review of the
protocol (ASP# 05-53, LRB) by the NIEHS animal care and use
committee. 6–10 week old male C57BL/6 mice (The Jackson
Labs, Bar Harbor, ME, USA) were used in all experiments. Mice
were housed and maintained in specific pathogen-free conditions.
For treatments, anesthetized mice were made to aspirate
intratracheally N-RNA, Ino-RNA at indicated concentration or
vehicle control (PBS). After indicated times, bronchoalveolar
lavage (BAL) was performed using phosphate buffered saline.
ELISA was then used to measure the levels of cytokines in the BAL
Figure 1. In vitro transcription of inosine-containing RNA. RNA was synthesized using Megascript in vitro transcription assay (Ambion, Austin,
TX, USA) and pGEM-Luc vector (panel A) as template (Promega, Madison, WI). For RNA with inosine content, inosine tri-phosphate (Sigma, St. Louis,
MO, USA) was added to the reaction mixture. Panel B, to quantify incorporation of inosines, RNA was digested by phosphodiesterase and was then
separated by HPLC. Relative nucleoside incorporation was determined by calculating the area under each peak. The synthesized RNA is 0% (a), 6% (b),
10% (c) or 16% (d) inosines incorporations.
doi:10.1371/journal.pone.0026463.g001
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genetically-deficient in PKR and wild-type control C57BL/6/
SV129 were used. After 4 hr treatments, lung tissues were
harvested for RT-PCR.
For flow cytometry, BAL cells were first treated with rat anti-
mouse CD16/CD32 (BD Pharmingen, San Jose, CA, USA) and as
immunoglobulin receptor blockers (Jackson ImmunoResearch,
West Grove, PA, USA). Then, one microgram of each monoclonal
antibody specific to CD11c (APC), Gr-1 (PE-Cy7) and major
histocompatibility complex Class II (MHC II)- FITC (eBios-
ciences, San Diego, CA, USA), were added and incubated for
30 min on ice. Cell acquisition and analysis were performed on a
BD LSR-II flow cytometer using FACSDiva software (version
4.1.2, Beckton Dickinson).
Confocal microscopy
10% Ino-RNA was labeled with Cy3 using Mirus RNA
labeling kit (Madison, WI, USA). Labeled RNA was then
purified with RNAeasy mini kit (Qiagen, Valencia, CA, USA).
Cells were grown in glass-bottom microwell dishes (MatTek
Corp., Ashland, MA, USA) and were treated with 10 mg/ml of
Cy3-labeled 10% Ino-RNA alone or were first treated with
10 mg/ml of dextran sulfate or feutin (Sigma Chemicals, St.
Louis, MO, USA). After 5 min, cells were washed 3 X in PBS,
and mounted with mounting medium (Vector Lab, Burlingame,
CA, USA).
Gene array analysis
Gene expression analysis was conducted using Agilent Whole
human Genome 4x44 multiplex format oligo arrays (Agilent
Technologies, Santa Clara, CA, USA) following the Agilent 1-
color microarray-based gene expression analysis protocol. Starting
with 500 ng of total RNA, Cy3 labeled cRNA was produced
according to manufacturer’s protocol. For each sample, 1.65 mgo f
Cy3 labeled cRNA was fragmented and hybridized for 17 hr in a
rotating hybridization oven. Slides were washed and then scanned
with an Agilent Scanner. Data was obtained using the Agilent
Feature Extraction software (v9.5), using the 1-color defaults for all
parameters. The Agilent Feature Extraction Software performed
error modeling, adjusting for additive and multiplicative noise.
The resulting data were processed using the Rosetta ResolverH
system (version 7.2) (Rosetta Biosoftware, Kirkland, WA, USA).
Results
In vitro synthesis of RNA and inosine quantitation
To examine our hypothesis that the presence of inosines in
ssRNA from any source was an innate immune stimulus, we used
Figure 2. Ino-RNA activates primary human cells. Panel A, In vitro transcribed N-RNA and Ino-RNA (6%, 10% and 16% inosine content) were
added directly to PHBE cells at 10 mg/ml final concentration. After 2 hr, total RNA was extracted and used in real-time RT-PCR (n$4). We next
performed a concentration curve using Ino-RNA with 10% inosine content (2 hr, panel B, n=4) and kinetic studies (panel C) analysis of Ino-RNA
induction of inflammatory cytokines (n=4). Panel D, treatment of primary human alveolar macrophages with N-RNA and 10% Ino-RNA (n$4). Error
bars indicate standard error of the mean (6 SEM, *p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0026463.g002
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normal RNA (N-RNA) and inosine-containing RNA (Ino-RNA)
(Figure 1). The inosine content of the RNA was then quantified by
phosphodiesterase digestion followed by HPLC separation and
quantification (Figure 1B). Quantitative analysis showed that we
routinely synthesized RNA with 6%, 10% and 16% inosines
incorporations, which is similar to A-I editing of RNA during virus
infections [14,23]. Experiments using a second template, Xenopus
elongation factor 1a, gave identical results (data not shown).
Ino-RNA induced inflammatory cytokines and
chemokines in human epithelial cells and macrophages
To assess the effect of Ino-RNA on innate inflammatory
responses, we first treated PHBE cells with N-RNA and Ino-
RNA (10 mg/ml) containing 6%, 10% and 16% inosine
incorporation (Figure 2A). RT-PCR on total RNA showed that
inosine incorporation induced inflammatory cytokines. Treat-
ment of the cells with N-RNA did not show such increase.
Interestingly, we also did not observe any significant increase of
inflammatory cytokines by the addition of single stranded poly I
or poly C. When Poly I:C (double stranded) was used as a
positive control, a significant increase in inflammatory cytokines
was observed (Figure 2A). Also, RT-PCR data showed that there
was a time- and concentration-dependent induction of inflam-
matory markers when cells were treated with Ino-RNA (Figure 2B
and C). It is interesting to note that the level of TNF-a reached
maximum at 2 hr but other cytokines and chemokines continued
to increase up to the 4 hr time point. The reason for this
difference is not exactly clear, but it may reflect divergent
signaling mechanisms between TNF-a and other cytokines and
chemokines. Alternatively, there may be an early and specific
mechanism to reduce TNF-a expression. Consistent with data
from PHBE cells, treatment of primary human alveolar
macrophages with 10% Ino-RNA also showed significant
induction of TNF-a,I F N - b and IL-6, as compared to treatment
with N-RNA (Figure 2D ).
Figure 3. RSV replication is reduced by Ino-RNA treatment. Panels A, PHBE cells, were treated with 10% Ino-RNA (20 mg/ml for), N-RNA
(20 mg/ml), or IFN-a (1000 Units/ml) for 24 hr prior to RSV infection at 0.1 PFU/cell. Cells were collected after an additional 24 hr, for RNA extraction.
Total RNA from infected cells were extracted for RT-PCR quantification of RSV-NS1 transcript (n$3). Panel B, BEAS-2B cells were treated with 10%
Ino-RNA (5, 10, 20 mg/ml), N-RNA (5,10, 20 mg/ml) (n$3). Panel C, BEAS-2B cells were treated as above and after 48 hr infection with RSV at MOI of
0.1 PFU/cell, plaque assays were performed (n=3). Error bars indicate standard error of the mean (6 SEM, *p,0.05).
doi:10.1371/journal.pone.0026463.g003
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Next, we examined whether the induction of inflammatory
cytokines resulted in establishment of antiviral state during RSV
infection. PHBE and BEAS-2B cells were treated with N-RNA or
10% Ino-RNA (10 mg/ml). After 24 hr, cells were infected with
RSV at MOI of 0.1 pfu/cell. Cells were then collected after an
additional 24 hr, for total RNA extraction, or 48 hr for plaque
assays.
Data in Figure 3A and 3B showed that in both BEAS-2B cell
line and in PHBE cells, Ino-RNA treatment significantly reduced
viral replication as indicated by reduction in expression of RSV
NS1 (non-structural protein-1) gene. The plaque assay, Figure 3C,
confirmed the results of RT-PCR assays. These data suggest that
Ino-RNA triggers an antiviral state during RSV infection,
Ino-RNA induces innate immune responses in vivo
To determine the effect of Ino-RNA in vivo, we used C57BL/6
mice. Mice were treated with PBS, N-RNA or 10% Ino-RNA.
After 24 hr, BAL fluid cells were harvested and used for ELISA
and flow cytometry (Figure 4). Results of the ELISA showed that
compared to N-RNA, Ino-RNA induced a dose-dependent
increase in IL-6 and TNF-a proteins (Figure 4A). We used flow
cytometry to test influx of neutrophils into the lungs. As shown in
Figure 4B, the increase in N-RNA and Ino-RNA induced influx of
neutrophils into the lungs were approximate 2-fold and 8-fold
respectively compared to that of PBS treatment. Consistent with
our results obtained with human epithelial cells and macrophages,
Ino-RNA induced a significant increase in inflammatory cytokines.
The presence of inosines increases secondary structures
of RNA
We next tested whether inosines incorporation modified the
RNA structure. Previous work by others showed that inosines
decreased RNA secondary structure [32,33]. However, since
inosine pairing with other nucleotides is promiscuous, we
hypothesized that there was a possibility for formation of
secondary structures. To test this, we performed RNA structural
analysis. First, we used electrophoresis in a non-denaturing
agarose gel using Tris-Borate-EDTA (TBE) buffer as the
electrolyte. Ino-RNA migrated at a slower rate that N-RNA,
suggesting less secondary structure formation (Figure 5A, left
panel).
Since a critical factor in RNA structure formation is the presence
of cations such as magnesium and potassium, we then excluded
ETDA and included MgCl2 and KCl in both the electrolyte and the
loading buffer at approximate physiologic concentration of 4 mM
and 120 mM respectively. The inclusion of cations resulted in a
faster migration of Ino-RNA in the non-denaturing agarose gel
(Figure 5A, middle panel), despite the fact that inosine has higher
molecular weight than the nucleoside it is replacing, namely
guanosine. To verify that the faster mobility was due to structural
changes, we then used denaturing agarose gel electrophoresis. The
Figure 4. Ino-RNA induces inflammatory responses in C57BL/6 mice. Mice were intratracheally instilled with PBS, N-RNA or 10% Ino-RNA,
and BAL fluid was harvested after 24 hr. Panel A, cytokine protein levels were determined in BAL fluid by ELISA (n=3, 6 SEM, *p,0.05, *** p,0.001).
X-axis presents different RNA concentration. Panel B, flow cytometry analysis of neutrophil recruitment in BAL.
doi:10.1371/journal.pone.0026463.g004
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denaturing condition (Figure 5A, right panel).
We next used the metachromatic stain acridine orange to study
RNA structures. Upon binding to ssRNA acridine orange
fluoresces at 640 nm and upon binding to dsRNA the emission
is at 530 nm [34,35]. The fluorescence studies showed that in the
presence of magnesium and potassium, Ino-RNA contained more
secondary structures (Figure 5B). These results, which are
consistent with the results from the non-denaturing agarose gel
electrophoresis data, confirm that Ino-RNA contains more
secondary structures than N-RNA.
PKR is a dsRNA specific enzyme that is also activated by
secondary structures present in ssRNA [31]. To confirm the direct
interaction of Ino-RNA with PKR, we performed in vitro kinase
assays using purified recombinant PKR (Figure 5C) and BEAS-2B
cell extract (Figure 5D). Reactions were performed according to
materials and methods and autophosphorylation of PKR was
detected by western blot analysis. The data in Figure 5C and D
showed that the PKR was activated more robustly by Ino-RNA as
compared to N-RNA.
To further determine the increased secondary structures of Ino-
RNA, we used two different viral proteins that specifically bind
Figure 5. Inosines incorporation increases secondary structures of RNA. Panel A, N-RNA, 6%, 10% and 16% Ino-RNA were electrophoresed
on non-denaturing or denaturing agarose gels in the absence or presence of MgCl2 and KCl. Panel B, RNA secondary structures were determined by
acridine orange staining in the presence of MgCl2 and KCl followed by fluorescence spectral analysis. Panel C, Direct interaction of purified
recombinant PKR with Ino-RNA was examined by in vitro kinase reaction followed by western blot analysis. Panel D, BEAS-2B cell extracts were used
in in vitro kinase reaction in the presence of N-RNA (3 mg/ml), 10% Ino-RNA alone (3 mg/ml) or Ino-RNA incubated with increasing amounts of dsRNA-
binding protein E3L at 50, 100 and 200 ng. Panel E, PHBE cells were treated with 10% Ino-RNA alone, with Ino-RNA and E3L, Ino-RNA and Galpha-i
protein (Gp) (as a negative control). After 2 hr of incubation, total RNA was collected and RT-PCR reaction was performed (n$3, 6 SEM, *p,0.05,
**p,0.01).
doi:10.1371/journal.pone.0026463.g005
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[36,37]. The in vitro kinase reactions showed that E3L inhibited
Ino-RNA activation of dsRNA binding protein (PKR) (Figure 5D).
Similar data was obtained using s3 protein (data not shown).
Furthermore, the inflammatory cytokine induction in PHBE cells
by Ino-RNA was significantly inhibited by incubation of Ino-RNA
with E3L prior to treatment of the cells (Figure 5E), suggesting that
secondary structures in Ino-RNA are required for cell activation.
Internalization of Ino-RNA is through SR-A-mediated
endocytosis
To identify the receptor that is involved in the recognition of
Ino-RNA on epithelial cells, we tested SRs as possible candidates.
Previous studies from our laboratory showed that SR-A is a cell
surface receptor for dsRNA [1]. To visualize the role of SR-A in
internalization of Ino-RNA, we used Cy3 fluorescence labeling.
After 5 min incubation, cells were washed with PBS and examined
by confocal microscopy. In Figure 6A, the data showed that
labeled Ino-RNA entry into the cells within 5 min. Furthermore,
Ino-RNA was not internalized when cells were treated with
competitive antagonists dextran sulfate before the addition of Cy3-
labeled Ino-RNA. The data revealed that dextran sulfate, a
specific ligand of SR-A, inhibited uptake of Ino-RNA. However,
fetuin, a SR-Bspecific ligand, did not decrease Ino-RNA
internalization. We further examined the role of scavenger
receptors in Ino-RNA induction of inflammatory cytokines. PHBE
cells were treated with Ino-RNA in the presence or absence of
competitors, and after 2 hr total cellular RNA was harvested and
was subjected to real-time RT-PCR (Figure 6B). The data was
consistent with that obtained from confocal microscopy. These
data suggest that SR-A is involved in the internalization in PHBE
cells.
To characterize the downstream pathways, we used the
endosomal acidification inhibitor bafilomycine A (BFA), which
prevents adequate function of endosomal compartment [38] and
recognition by endosomal TLR3 [39]. In Figure 6C, BFA
completely blocked cytokine production induced by Ino-RNA.
Our data showed that Ino-RNA was recognized by cell surface
receptor SR-A and internalized through endocytosis. It was
therefore possible that Ino-RNA triggers SR-A-mediated endocy-
tosis and was sensed by TLR3 in endosome.
Downstream intracellular signaling pathways
Since our data showed that Ino-RNA contained more
secondary structures, we next determined whether dsRNA-specific
signaling pathways could be activated by Ino-RNA. PHBE cells
were treated with Ino-RNA at 10 mg/ml and at various times, cell
extracts were prepared for western blot analysis. The data showed
that there was a rapid activation of dsRNA-specific protein kinase
PKR, and the downstream signaling molecules such as eukaryotic
initiation factor-2a (eIF-2a), p38 MAPK and JNK (Figure 7A).
Treatment of cells with N-RNA did not activate these signaling
pathways (data not shown).
Recent reports have shown that TLR3, MDA5 and RIG-I
[3–5] sense viral RNA to initiate host innate immune responses.
To test which of these RNA sensors may be involved in
Figure 6. Ino-RNA internalization is through SR-A-mediated endocytosis. Panel A, Involvement of scavenger receptors in uptake of 10%
Ino-RNA was determined by using dextran sulfate or fetuin. PHBE cells were treated with 10 mg/ml Cy3-labeled Ino-RNA for 5 min, or were treated
with 10 mg/ml dextran sulfate or fetuin immediately before addition of Ino-RNA. After 5 min, cells were washed, mounted, and were used in confocal
microscopy. Panel B, PHBE cells were treated with dextran sulfate or fetuin immediately before treatment with 10% Ino-RNA. After 2 hr total RNA
was extracted and used in real-time RT-PCR. Panel C, PHBE cells were treated with endosomal acidification inhibitor BFA (100 nM) for 45 min and
then 10% Ino-RNA for 2 hr. The total RNA was extracted and used in real-time RT-PCR. Error bars indicate standard error of the mean (n=3, 6 SEM,
**p,0.01).
doi:10.1371/journal.pone.0026463.g006
Ino-RNA Activates Anti-Viral Responses
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26463Figure 7. Ino-RNA-induced signaling pathways. Panel A, For analysis of innate inflammatory signaling pathways, PHBE cells were treated with
Ino-RNA at 10 mg/ml and at indicated time points, total cellular protein extracts were prepared by cell lysis using 1X SDS-PAGE buffer. Phospho-
proteins were probed using specific antibodies, and were visualized by the enhanced chemiluminescence detection. Panel B, For the activation of
MAPKs detection, PKR, TLR3, MDA5 and RIG-I were treated by chemically synthesized siRNAs and then by 10% Ino-RNA. We next performed analysis
of Ino-RNA induction of inflammatory cytokines following PKR, TLR3, MDA5 and RIG-I siRNA knockdown (Panel C, n=3). Mock siRNA-treated cells
were used as a control. Panel D, PKR-deficient mice or wild-type controls (4 in each group, n=3) were treated intratracheally with 25 ml (1 mg/ml) of
Ino-RNA or with 25 ml of PBS (vehicle control). After 4 hr, total lung RNA was isolated for RT-PCR (n=3, 6SEM, *p,0.05, ** p,0.01).
doi:10.1371/journal.pone.0026463.g007
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down the corresponding proteins using siRNAs. As shown in
Figure 7B, the knockdown of TLR3 and PKR, but not that of
MDA5 and RIG-I, impaired the activation of p38 and JNK
MAPKs in response to Ino-RNA treatment. In identical
knockdown experiments, our data showed that TLR3 and
PKR but not MDA5 or RIG-I were necessary for inflammatory
cytokine induction (Figure 7C).
Our results obtained with the knockdown of PKR provide
strong evidence that the PKR protein was an important mediator
of MAPK signaling activated by Ino-RNA. To directly evaluate
the role of PKR in Ino-RNA induction of immune responses in
vivo, PKR
-/- and wild type control mice were used. We examined
the effect of PKR deficiency on cytokine expression. Total cellular
RNA was extracted from lungs and was subjected to RT-PCR. As
compared to the wild type, the lungs from PKR
-/- mice exhibited
significantly diminished expression of TNF-a, IFN-b and IL-6
(Figure 7D).
Global transcriptomic analysis
To identify genes that were induced by Ino-RNA, global gene
expression profiling was performed using labeled cRNA derived
from total RNA extracted from cells that were treated with N-
RNA or with RNA containing 10% inosines. Data were then
vigorously filtered to remove biases. The genes that were
significantly induced only by 10% Ino-RNA over 2 fold were
considered for further analysis. Analysis of our data showed that
10% Ino-RNA treatment induced 132 genes in PHBE cells
(Table 1). Genes that are associated with antiviral immune
responses are shown in Table 2. Genes that were highly induced
by Ino-RNA are associated with antiviral responses, innate and
adaptive immunity, and cell signaling (Figure 8). Collectively, these
data suggest that Ino-RNA is a potent inducer of innate immune
and antiviral genes.
Discussion
In this report we provide evidence to show that extracellular
single Ino-RNA is a recognition element for innate immune
activation during RSV infections. We demonstrated this by both in
vitro and in vivo experiments using PHBE cells, primary human
macrophages and animal experiments (Figure 2 and 4). Previous
reports have shown that infected eukaryotic cells recognize viral
infections by the presence of different viral RNA structures, such as
dsRNA and 59-triphosphate ssRNA. Recognition of viral RNA
structures activates cell signaling through molecules such as SR-A,
PKR, TLR3, RIG-I, MDA5, NLRP3 and MAVs [1–7]. Our data
shows that Ino-RNA has increased secondary structures that
activate intracellular signaling pathways and subsequently induced
innate inflammatory cytokines. We further report that extracellular
Table 1. Microarray analysis of RNA from PHBE cells treated
with Ino-RNA.
Treatment Upregulated genes Downregulated genes
N-RNA 12 10
Ino-RNA 132 29
Numberofgenesthatweresignificantlychangedover2foldinN-RNA-treatedcells
vs. untreated cells and 10% Ino-RNA-treated cells vs. untreated cells (10 mg/ml) at 2
hr (n=3).
doi:10.1371/journal.pone.0026463.t001
Table 2. List of significant genes associated with antiviral and innate immune responses that are induced by 10% Ino-RNA and not
by N-RNA.
Gene Fold Change p-Value
tumor necrosis factor 15.66287 1.52E-03
superoxide dismutase 2, mitochondrial 7.86062 7.42E-03
interferon-induced protein with tetratricopeptide repeats 2 6.36192 9.00E-05
chemokine (C-X-C motif) ligand 10 5.89583 5.20E-04
lymphotoxin beta (TNF superfamily, member 3) 4.58494 1.30E-04
interferon regulatory factory 1 3.66301 3.63E-03
chemokine (C-X-C motif) ligand 11 3.58219 1.40E-04
complement component 3a receptor 1 3.02745 2.26E-03
Interleukin 7 receptor 2.72687 1.28E-03
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 2.71986 5.82E-03
endothelin 1 2.54256 4.70E-04
T-cell leukemia/lymphoma 6 2.50143 5.34E-03
human Alu subfamily J 2.49559 2.18E-03
chemokine (C-X-C motif) ligand 1 2.48883 2.50E-03
protein kinase C, gamma 2.39706 5.42E-03
cathepsin G 2.37645 2.22E-03
serine/arginine repetitive matrix 1 2.33647 3.61E-03
inositol polyphosphate-5-phosphatase 2.28572 9.08E-03
interleukin 8 receptor, alpha 2.08874 8.72E-03
chemokine (C-C motif) ligand 3-like 1 2.06591 1.19E-03
CD5 molecule 2.02828 7.05E-03
doi:10.1371/journal.pone.0026463.t002
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TLR3 (Figure 6). The downstream MAPK signaling pathway is
dependent on TLR3 and PKR but not cytosolic sensors such as
MDA5 and RIG-I (Figure 7).
Previous studies by others and our laboratory showed that
dsRNA was a critical signal for the presence of viral infections
and induction of innate inflammatory responses [10,11,40,41].
However, the amount of dsRNA that is formed during infections
has remained controversial [42]. The presence of Ino-RNA during
virus infections requires activation of enzyme ADAR-1, a dsRNA-
activated adenine deaminase. Therefore, it is possible that small
amount of dsRNA present during infections activates this enzyme
that subsequently lead to a more abundant Ino-RNA presence.
Previous reports have demonstrated activation of this enzyme
Figure 8. Global transcriptomic analysis. Panel A, Ingenuity Bio-Function Analysis of genes upregulated (.2 fold) in 10% Ino-RNA-treated cells
but not in normal RNA-treated cells. Panel B, Ingenuity Canonical Pathway Analysis of genes upregulated (.2 fold) in Ino-RNA treated cells but not
in normal-RNA treated cells.
doi:10.1371/journal.pone.0026463.g008
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suggesting that dsRNA is present at certain time points during
viral life cycles [12–19]. Since significant portion of adenosine in
cellular and viral RNA can be converted to inosines during viral
infections [14,20,22,25–28], it is plausible that the presence of
abundant intracellular or extracellular Ino-RNA is a potent
stimulus for immune activation. Our data obtained from in vitro
and in vivo experiments confirmed this assertion (Figure 2 and 4).
Interestingly, the previous work on activation of cells was nearly
entirely done using the synthetic homo-bipolymer poly inosinic:
poly cytidylic acid (poly I:C). This is likely due to the fact that poly
I:C has been the most potent inducer of type-I interferons, and
other ds- or ssRNA polynucleotides have not been as effective
[42]. The molecular basis for superior efficiency of poly I:C over
other dsRNA polymers is not yet known. It is tempting to
speculate that inosines may be a requirement for efficient
activation of innate immunity during virus infection.
Our data, based on four different observations, demonstrated
that incorporation of inosine in ssRNA increased secondary
structures. First, our data showed that PKR, an intracellular
dsRNA-specific kinase was activated by Ino-RNA more than with
N-RNA (Figure 5 C and D). We next confirmed the formation of
RNA secondary structures using vaccinia virus dsRNA-binding
protein E3L. Incubation of Ino-RNA with E3L effectively blocked
PKR activation and cytokine expression in PHBE cells (Figure 5E),
suggesting that Ino-RNA contained secondary structures. We also
reconfirmed this by using the reovirus s3 dsRNA binding protein
(data not shown). Secondly, during agarose gel electrophoresis in
the presence of magnesium and potassium Ino-RNA migrated at a
faster rate than N-RNA (Figure 5A, middle panel) and the band
intensity of Ino-RNA was more than N-RNA. Lastly, the acridine
orange spectral analysis showed that incorporation of inosines into
RNA increased fluorescence emission (Figure 5B).
A report by Hartner et al. showed that, using ADAR1-deficient
mice, ADAR1 was necessary for the maintenance of hematopoi-
etic stem cells and suppression of interferon [43]. They suggested
that ADAR-1 has a baseline intrinsic or perhaps secondary
function in liver cells. Scadden et al. presented an alternative
explanation for the role of ADAR1 in interferon signaling [44].
They proposed that intracellular short IU-pairs in short (20 bp)
dsRNA, such as in miRNA suppress interferon induction and
apoptosis in cells. In our studies, long (.1 Kb) inosine-containing
ssRNA was used which led to an increase in secondary structures
and activation of PKR and cytokine expression. These are likely
differences due to length of RNA and the possible presence of
multiple secondary structures in long inosine-containing RNA.
Inosines can pair with any nucleotide and therefore, our data are
consistent with the possibility of increased secondary structures
after ADAR-1 activation.
Our in vitro structural analysis data showing increased secondary
structures after inosine incorporation are not consistent with
previously published data [32,33]. This is likely caused by the
absence of magnesium and potassium in the other experiments.
Cations such as magnesium and potassium are requires for
formation and stabilization of RNA secondary structures. In our
experiments, data obtained from both electrophoresis and spectral
analysis in a buffer lacking magnesium and potassium showed that
the Ino-RNA contained less structure than N-RNA (Figure 5A, left
panel). However, in the presence of cations, Ino-RNA ran at a
faster rate than N-RNA (Figure 5A, middle panel), showing that
inosine incorporation increased secondary structure (Figure 5B).
Gamper et al. also reported that inosines incorporation into RNA
reduced secondary structure in buffer with cations [33]. In their
study, transcripts were less than 60 bp long, and inosine content in
the RNA was 25%. It is possible that with short transcripts and
high inosine content, the secondary structures, are less stable. In
our experiments, 1.8 kb transcript with 10% inosine content was
used, which is close in size to viral and cellular transcripts. It is
known that inosines are promiscuous in their base pairing with
other nucleotides, therefore, increased secondary structures in the
presence of appropriate cations at physiological concentrations is a
very likely event.
It’s known that, during virus infection, ADAR activation leads
to adenosine to inosine conversion. In our in vitro transcription
experiment, guanosines triphosphate are replaced by inosine
triphosphate (Figure 1), however, we believe that presence of
inosines at any sites within RNA will likely increase secondary
structures. In addition, we obtained similar results using a different
template (Xenopus elongation factor 1 (data not shown).
RNA secondary structures are metastable, nonetheless they can
activate innate immune responses. Interestingly, Nallagatla et al.
reported that secondary RNA structures capable of activating
PKR were also formed in 59-triphosphate ssRNA [31], and
capping of 59-tri-phosphate RNA abrogated secondary structures
and PKR activation. Collectively, the accumulated data demon-
strated that formation of secondary RNA structure is a critical
factor for viral recognition. Our data in Figure 2 and 3 showed
that Ino-RNA induced the expression of TNF-a, IFN-b and the
antiviral state. It is known that TNF-a and IFN-b inhibit RSV
replication [45–48] and our observation that Ino-RNA reduces
RSV replication may in part be the result of cytokine expression.
Previous work showed that SR-A was a surface receptor for
extracellular dsRNA [1,30]. Based on our current data, we
propose that SR-A also functions as a surface receptors for
extracellular Ino-RNA (Figure 6 A and B). After internalization,
Ino-RNA may escape the endosome and interact with PKR
directly in the cytoplasm (Figure 5 C and D). It is also possible that
Figure 9. Proposed model of extracellular Ino-RNA-induced
antiviral activity.
doi:10.1371/journal.pone.0026463.g009
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and then activates downstream PKR (Figure 7 B, C and D).
Previous study reported that PKR played an important role in
TLR3-mediate downstream signaling through interaction with a
member of MAP kinase kinase Kinase family [49]. We previously
reported that SR-A uptake of dsRNA resulted in downstream
PKR activation and MAPK signaling pathways, which induced
inflammatory cytokines in epithelial cells [1]. The data in this
study further confirm the role of SR-A in Ino-RNA-activated
signaling pathways. Knockdown experiments showed that TLR3
and PKR but not MDA5 or RIG-I can significantly reduced p38
and JNK phosphorylation induced by Ino-RNA (Figure 7 B and
C). Therefore, we propose that extracellular Ino-RNA-induced
antiviral innate immune responses are mediated through PKR and
TLR3-dependent pathways (Figure 9). It has been reported that
poly I directly added to cells activates B lymphocytes and dendritic
cells through a TLR3-dependent and SR-A independent pathway.
The differences could be due to different cell [50].
Our global transcriptomic analysis on RNA isolated after 2 hr
of treatment showed that 132 genes were preferentially induced by
Ino-RNA (Table 1). Several of these genes, such as TNF-a and
interferon regulatory factor-1 are relevant to antiviral immune
responses (Table 2). It is noteworthy that several cytokines and
chemokine receptors were also induced by this treatment,
presumably to increase immune cell infiltration into the infected
tissue. This is consistent with our in vivo data showing an increase
in neutrophil infiltration into the lungs of Ino-RNA-treated mice
(Figure 4B).
We therefore suggest that fof RNA with secondary structures
through an increase in inosines and subsequent activation of
intracellular signaling pathway is a critical step in cellular and
immune activation.
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